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Abstract
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system that affects close to 400,000 patients in the United States and roughly 2.3
million people around the world. Because this is a growing global public health concern,
researchers and clinicians are calling for a more efficient adoption of these McDonald
MS guidelines in clinical practice as outlined in newly diagnosed guidelines. The purpose
of this quantitative correlational study was to examine the relationship between the
independent variables gender, guidelines knowledge, years in practice and intent to use
the McDonald MS guidelines for diagnosing MS among physicians. The diffusion of
innovation model was used to help understand and interpret the findings. The study
sample consisted of 161 practicing physicians who treat MS patient in the Midwestern
United-States recruited using convenience purposeful sampling. Data were collected by
electronic survey using Survey Monkey. Binary logistic and multiple logistic regression
to test the association between variables yielded no association between variables or the
presence of predictor for the outcome. Analysis revealed gender (odds ratio [OR] =1.5;
p=.347), knowledge (OR=1.23; p= .600), and years in practice (OR=1.015; p=.404) were
not a predictor of intent. These findings contradict research on factors affecting the
adoption of new technologies in fields other than treatment of MS. The positive social
change impact of understanding factors associated with the adoption of the guidelines by
clinicians is a resulting increase in use for effective diagnoses of MS.
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Chapter 1: Introduction to the Study
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the
central nervous system that affects close to 400,000 patients in the United States and
roughly 2.3 million people around the world (Tullman, 2013), which has led to a growing
global public health concern. (World Health Organization, 2016). Guidelines exist to help
patients with diagnosing and treatment of MS. However, researchers and clinicians are
calling for a more efficient adoption of these guidelines in clinical practice (Harris,
2009). The McDonald guidelines may improve disease diagnosis, predict disease
progression, and improve clinical outcome (Harris, 2009). The topic of the study is
physicians’ perceptions and intent to use MS McDonald guidelines for diagnosing MS.
Appropriate use of guidelines by frontline clinicians could result in earlier detection of
MS, reducing associated morbidity and mortality associated with the disease. Study
findings may impact secondary and tertiary MS prevention efforts in the community.
This chapter includes a discussion of the background, research questions (RQs), purpose
of the study, and theoretical framework for the study.
Background
Physicians’ perceptions on the use of MS guidelines are hampered due to the lack
of understanding for the etiology of MS, lack of specificity, and cost (Harris, 2009).
However, it is necessary for clinicians to have appropriate understanding of the etiology,
as well as a guideline that they can correctly use. This can make a difference in public
health because as the prevalence of MS is increasing, quality of care for these patients is
becoming a growing concern. The National MS society has reported the prevalence of
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MS to be 2.3 million individuals worldwide and 400,000 in the United States (Tullman,
2013). In the United States prevalence estimates are 90 per 100,000, and 10,000 new
cases are diagnosed each year or 200 new cases per week (Pohlman et, al., 2010). MS can
affect individuals between the ages of 20 and 50.
The current diagnostic tools for MS include MRI of the brain and spinal cord,
lumbar puncture to evaluate cerebrospinal fluid (Villoslada, 2010). But there is a need for
clinicians to correctly use guidelines, which could provide intervention to prevent
advanced MS disease. Guidelines that currently exist focus on myelin loss, spinal cord
disease, gray matter, and subcortical demyelination (Villoslada, 2010). The discovery of
innovated guidelines will depend on significant advances in proteomics and microarray
gene and antigen analysis (Gandhi et, al.,2013). Although guidelines currently exist for
MS, there is a need for clinicians to correctly use McDonald guidelines for diagnosing
MS to improve community care and clinical outcomes (Martin et, al., 2006). But there is
little research about clinicians’ level of knowledge and perceptions of the use of
guidelines for diagnosing MS. Findings from this study will contribute to closing this gap
in the literature. The purpose of this quantitative correlational study is to examine the
association between physician factors and characteristics that may be associated with
their intent to use guidelines for early diagnosis and prevention of advanced forms of MS.
Problem Statement
Physicians find it clinically valuable to have a measuring tool such as guidelines
to definitively diagnose, identify reoccurrence, and treat MS (Mehr, 2015). However,
there is a lack of consistent guidelines to diagnose and treat MS (Harris, 2009). Not
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correctly using measurable tools for accurate, early diagnosis results in poor clinical
outcomes for the community suffering from MS (Mehr, 2015). The correct use of
guidelines by front line clinicians is needed so that patients can be diagnosed and treated
more effectively to prevent reoccurrences of MS related complications (Harris, 2009).
But there is not enough research on what clinicians know about guidelines when
diagnosing MS along with their attitudes and beliefs particularly when looking at
physician gender, McDonald MS guideline knowledge, and years in practice. With this
study, findings may encourage use of MS guidelines to diagnose and treat patients, which
may lead to earlier detection and improved patient outcomes.
Purpose
The purpose of this quantitative correlational study was to examine the
relationship between the independent variables gender, McDonald MS guideline
knowledge, and years in practice, and the dependent variable of intent to use guidelines.
The variables were analyzed with correlation, bivariate, and multivariate logistic
regression. This study may impact MS prevention efforts by indicating factors that affect
use of guidelines to diagnose and treat MS patients.
Research Questions and Hypotheses
The research questions (RQs) and accompanying null and alternative hypotheses
for this study are:
RQ1: What is the association between gender and the intent to use the guidelines?
Null Hypothesis: There is no association between gender and intent to use the
guidelines.
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Alternative Hypothesis: There is an association between gender and intent to use
the guidelines.
RQ2: What is the association between guidelines knowledge and intent to use the
guidelines.
Null hypothesis: There is no association between guidelines knowledge and intent
to use the guidelines.
Alternative Hypothesis: There is an association between guidelines knowledge
and intent to use the guidelines.
RQ3: What is the association between years in practice and intent to use the MS
guidelines?
Null Hypothesis: There is no association between years in practice and intent to
use the guidelines.
Alternative Hypothesis: There is an association between years in practice and
intent to use the guidelines.
RQ4: To what extent do gender, guideline knowledge, and years in practice
predict intent to use the guidelines?
Null hypothesis: Gender, guidelines knowledge, and years in practice do not
predict intent to use guidelines.
Alternative Hypothesis: Gender, guidelines knowledge, and years in practice
predict intent to use guidelines.
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Theoretical and Conceptual Framework for the Study
I used the Diffusion of Innovation Model to help me understand and interpret my
findings (Rogers, 1995). This model was appropriate because it looks at the how, why,
and at what rate technology can spread. Adoption means that a person does something
differently than what they had previously done, and the key to adoption is that the person
must perceive the idea, behavior, or product as new or innovative (Rogers, 1995). The
steps in diffusion consist of knowledge, persuasion, decision, implementation, and
confirmation. Though the diffusion of innovation model is important when evaluating
technology acceptance and sustainability (Aizstrauta, 2014), in the context of this study,
it takes this type of new adoption for clinicians to realize the importance of guidelines for
MS since there is an underutilization of guidelines with MS patients. The clinical use of
guidelines in early detection and risk assessment will recognize an important health care
need of detecting and monitoring MS at its earliest stage. The Diffusion of Innovation
Model helped me in my understanding of the data from the study.
Nature of the Study
This study was a quantitative cross-sectional correlation study in which I
examined the association between gender, McDonald MS guideline knowledge, and years
in practice and clinicians’ intent to the use the guidelines. This methodology was
appropriate for the study because it allowed me to quantify the association between the
variables. Independent variables in the study were gender, McDonald MS guideline
knowledge, years in practice, and the dependent variables was intent to use the
guidelines. I developed an electronic survey using Survey Monkey to collect data from
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161 practicing physicians from the Midwest who are in private practice or practicing at
major medical centers.
Definitions
The following section includes a list of key constructs and their definitions.
Multiple sclerosis (MS): Demyelinating and chronic disease of the central nervous
system in which the insulating covers of nerve cells in the brain and spinal cord are
damaged. This construct will measure how well biomarkers detect MS (Loma, 2011).
Gender: Biological designation of male or female (Miguez, 2014).
Guideline’s knowledge: Knowledge is the level of understanding and knowledge
about the McDonald MS guidelines (Guo, 2014).
Assumptions
The first assumption was that physicians’ knowledge about McDonald MS
guidelines may be varied. The second assumption was that guideline clinical use may be
varied, and clinicians responded truthfully to the questions on the survey. The advantages
are these more robust guidelines are clinically useful for clinicians to make a proper
diagnosis and treatment plan for the patients (Housley et, al., 2015).
Scope and Delimitations
The scope of the study focused on the selected physician characteristics gender,
McDonald guideline knowledge, and years and practice and the dependent variable intent
to use. I explored intent to use the McDonald guidelines only, not their actual use. The
populations included in the study include physicians who diagnose and treat MS patients
across the Midwest, and the exclusion includes population outside of the Midwest.
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Limitations
The limitations of this cross-sectional correlational methodology are that it is not
used to analyze behavior or establish cause and effect. The limitations to external validity
consisted of population and ecological validity. Another limitation is recall bias as this is
a main drawback to surveys.
Significance
Although McDonald MS guidelines may exist for MS there is a need for clinicians to
correctly use of guidelines for diagnosing MS to improve community care (Martin et, al.,
2006). But there is little research about clinicians’ level of knowledge and perceptions of
the use of guidelines for diagnosing MS. The public health concern for MS in the
community is the growing prevalence, disability, and cost of MS; with better use of
guidelines this burden could be reduced. Addressing clinicians’ perceptions can improve
their quality of care, cost, and access within the healthcare system. The appropriate use of
McDonald MS guidelines by frontline clinicians could result in earlier detection and
more effective treatment of MS thus reducing associated morbidity and mortality.
Summary
The prevalence of MS is growing including the diagnosis of MS. The purpose of
this quantitative correlational study was to examine the association between physician
characteristics that may be associated with their intent to use the McDonald guidelines
for early diagnosis and prevention of advanced forms of MS. It is important to examine
the association between physician factors and clinical factors like gender, McDonald MS
guideline knowledge, and years in practice with the intent to use the guidelines to better
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understand their implementation or lack of implementation in practice. Increased and
consistent use of the McDonald MS guidelines could result in earlier detection and more
effective treatment of MS thus reducing associated morbidity and mortality associated
with the disease. Roger’s Diffusion of Innovation Model was used to help me understand
and interpret my findings (Rogers, 1995). Data for this study were collected through an
electronic survey that was emailed to practicing clinicians from across the Midwest and
at major academic institutions. Chapter 2 includes a detailed literature review on MS and
the methodology.

9
Chapter 2: Literature Review
The implementation of guidelines by front line clinicians is needed so that
patients can be diagnosed and treated more effectively to improve patient outcomes and
establish more valid diagnostic tests and immunotherapies (Harris, 2009). For instance,
the McDonald MS guidelines can be used to definitively diagnose, identify reoccurrence,
and treat MS (Mehr, 2015). However, there is a need for a more efficient adoption of
these guidelines (Harris, 2009). It has been challenging to establish an effective guideline
because of the clinical and pathophysiological complexities of the disease (Katsavos et,
al., 2013). This understanding of which mechanism is most relevant is challenging in
deciding which is the appropriate therapeutically immunotherapy choice.
At present, the clinical application of neutralizing antibodies interferon beta as a
guideline is what clinicians are using to treat MS even though it lacks specificity and
sensitivity, and with current validation studies that are currently occurring, cerebral spinal
fluid (CSF) analysis of fetuin-A and other markers, such as ostepontin could be routinely
used and a more effective option (Harris, 2014). The current study discussed possible
guidelines that are relevant and include HLA-DRB1, polymorphisms, oligoclonal bands,
vitamin D, TOB-1, ApopE. S100B and conventional and nonconventional imaging
techniques to name a few (Katsavos et, al., 2013). But without an effective guideline it is
difficult to personalize the treatment with an effective immunotherapy. The clinical
management of patients with MS can improve with a reliable biomarker and improve
clinical outcome (Harris, 2014), which can be done using the McDonald guidelines. This
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chapter includes the literature search strategy and a comprehensive review of the relevant
literature on MS and the McDonald guidelines.
Literature Search Strategy
The databases used included the library resources at the Washington University
School of Medicine in St. Louis, St. Louis University School of Medicine, Lindenwood
University in St. Louis, and search engines included EBSCO host, google scholar. The
key search terms included were MS and guidelines, current research and development
with MS guidelines, current challenges or limitations of MS guidelines, and clinical
factors associated with clinician’s intent to use the guidelines. The years searched
included 2015-2020 for data and peer reviewed articles.
Theoretical Framework
I used the Diffusion of Innovation Model to help me understand and interpret my
findings (Rogers, 1995). This diffusion of innovation model is used to evaluate
technology acceptance and sustainability (Aizstrauta, 2014), determining the how and
why technology spreads. This model is appropriate for my study because it takes this type
of new adoption for clinicians to realize the importance of guidelines for MS.
Literature Review
Epidemiology of MS
MS is an acquired inflammatory and neurodegenerative immuno-mediated
disorder of the central nervous system, and its distinguishing features consist of
inflammation, demyelination, and primary and secondary axonal degeneration (Pugliatti
et, al., 2006). The clinical presentation of MS consists of visual and sensory disturbances,

11
limb weakness, gait problems, and bladder and bowel symptoms that often accompany
irreversible functional disability over time (Puglatti et, al., 2006).
MS affects 400,000 people in the United States and 2.5 million people worldwide
(Puglatti et, al., 2006). The prevalence estimates are 90 per 100,000 population and MS
symptom age can start anywhere from 20-50 to 80 years old, but mean age is 32
(Williamson, 2009). The lowest prevalence has been in the Texas area, intermediate in
the Missouri area, and highest in the Ohio area (Williamson, 2009). The United States
MS prevalence is highest among women, aged 40 to 59 years old and non-Hispanics, and
approximately 85% of affected people have a relapsing-remitting course, and an unsteady
course of exacerbations and remissions (Williamson, 2009). The latitude increase
gradient in MS incidence over the last 25 years tied to regions closer to the equator, and
an increase in the female to male ratio among MS cases (Alonso, 2008). Europe is
considered a higher region for MS with 30,000 per 100,000 and higher prevalence and
incidence tended to be higher in the Northern regions of the United Kingdom and in the
Nordic countries, suggesting the importance of the role of latitude (Kingwell et, al.,
2013). In Europe, the MS incidence is 4.3 cases per 100,000 and the total prevalence in
Europe the past three decades is 83 per 100,000 and higher rates in northern country and
a female to male ratio around 2.0 (Pugliatti et, al., 2006).
Some of the proposed causes of MS include genetics, smoking, and reproductive
factors (Alonso, 2008; Poorolajal et, al., 2017) The literature has also demonstrated that
the incidence of MS in influenced by numerous factors, including patient gender, age,
duration of illness, ethnicity, season, latitude, serum vitamin D levels, smoking, stress,
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infectious diseases, pregnancy, and assisted reproduction (Kalincik, 2015). Additional
factors that influence MS incidence include population genetics, the interplay between
genes and a geographically determined physical environment, socioeconomic structure
including the availability of medical facilities (Tullman, 2013). Additional research
shows that besides the established MS associated risk factors insufficient sun exposure,
dietary intake, Epstein-Barr virus infection, and obesity during adolescence all play an
important role and can lead to more cases of MS (Olsson et, al., 2017). In addition,
personality has been considered a difference in overall health and well-being, and those
individuals with a type D or distressed personality with MS tend to have poorer outcomes
(Strober, 2016). However, early-stage MS patients who had adequate levels of vitamin D
had a 57% lower rate of new brain lesions, a 57% lower relapse rate, and a 25% lower
yearly increase in lesion volume than those with lower levels of vitamin D (Harvard
School of Public Health, 2016).
Public Health Impact of MS
There is significant evidence that MS as a neurological disorder poses a great
threat to public health. MS disease characteristics significantly affect dimensions of
quality of life (Rezapour et, al., 2017). Major depression prevalence in those diagnosed
with MS in the 18 to 45-year-old range was high at 25.7% (Patten et, al., 2003). Not only
can depression be a public health concern for these MS patients, but there may be a
greater risk of harm to the MS patients due to substance abuse including alcohol and
illicit drug use in people with MS because of the possible magnification of motor and
cognitive impairments (Bombardier et, al., 2004).
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MS Prevention History and Current State of the Science
As stated, MS can be caused by strong environmental factors that include vitamin
D status, infection with Epstein Barr virus, and cigarette smoking (Ascherio, 2008). More
importantly genetic factors play a significant factor as well as the strongest risk factor for
MS is family history (Ascherio, 2008). The keys to MS prevention with these genetic risk
factors are the systemic screening of the whole genome. A large international consortium
has been established to identify the genetic determinants of MS as the HLA-DRB1 locus
has been linked along with additional loci to an MS risk (Asherio, 2008). Other
prevention methods for environmental causes of MS include moving to area of lower
latitudes because of the importance of the correlation of vitamin deficiency at higher
latitudes and MS incidence. (Asherio, 2008). Vitamin D effectively reduces the risk of
MS; thus, it is important to provide supplementation in adolescents and young adults.
Because of the correlation of smoking to MS, if smoking was eliminated, up to 6% of the
MS cases could be prevented (Asherio, 2008). Further, to prevent MS from further
progressing in diagnosed individuals, there are many recommended therapies (McNamara
et, al., 2017). However, MS is progressive disease with no cure, therefore MS may
worsen in some patients despite everything the patient and physician do (Murray, 2006).
MS Diagnostic History and Current State
MS diagnostic history in the 1980’s relied on the evidence of at least two relapses
typical of MS and evidence of white matter in more than one site in the central nervous
system (Murray, 2006). New research has shown new criteria known as McDonald
criteria which incorporates clinical and laboratory data, while looking at MRI imaging to
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demonstrate multiple areas of involvement and involvement over time (Murray, 2006).
These McDonald criteria also include the Barkhof-Tintore MRI criteria, which include
three of the four elements and at least one gadolinium enhancing lesion or 9 T2
hyperdense lesions, at least one infratentorial lesion, at least one juxtacortical lesion, and
at least 3 periventricular lesions, and a spinal cord lesion can substitute any of the above
brain lesions (Inglese, 2006) The current diagnostic criteria for MS are based on lesions
within the central nervous system that demonstrate dissemination in space and time
(Rovira, et, al., 2015). The high sensitivity of the MRI in the depiction of plaques in the
brain and spinal cord has made this technique valuable for diagnosing MS (Rovira et, al.,
2015). In addition, an MS diagnosis is dependent on a detailed medical history, careful
neurological examination, and additional paraclinical investigations such as MRI imaging
scans, CSF, evoked potentials, and blood tests (Inglese, 2006). The implementation of
MRI imaging reveals multifocal white cerebral white matter lesions in more than 95% of
patients and in 75-85% of these are focal spinal lesions (Inglese, 2006). However, no
single test including a tissue biopsy can provide a definite diagnosis of MS. The past few
years have seen improvement in the development of laboratory and imaging approaches
to the diagnosis of MS, but the use of diagnostic guidelines is important as well.
Lack of Correct and Consistent Use of McDonald Guidelines
One of the biggest challenges for clinicians is that the disease prognosis and
individual therapeutic outcomes can be difficult to predict with MS (Harris, 2014),
making it important to have a reliable guideline to detect MS and treat MS patients
(Harris, 2009).
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Some of the clinical parameters that physicians use depends on MS relapse rates,
MRI outcomes, and various changes in disability scores (Harris, 2009). Thus, there is an
unmet need for more sensitive and specific MS guidelines to better effectively diagnose
and treat MS. With more consistent and accurate guidelines, the clinicians will have an
accurate measurable tool that is better able to better assess and predict medical therapy
outcomes (Harris, 2009).
Despite the need for consistent guidelines, research on the etiology of MS is still
ongoing because it is difficult to confirm the exact etiology or cause of MS along with
understanding of the mechanism that is driving the disease (Harris, 2009). But MCAM
(melanoma cell adhesion molecules) are a potential diagnostic guideline for MS, as the
data show that the expression of the molecule on T cells correlates with MS disease
activity (Muccilli, et, al., 2017). The strength in this approach is that researchers are
looking for additional correlations across various disease states including a correlation to
melanoma in trying to identify a new diagnostic guideline. The weakness in this approach
is whether the peripheral expression of melanoma cell adhesion molecules can also
predict MS relapses.
Additionally, “NMO-IgG antibodies became the first clinically useful diagnostic
guideline that looked at a subgroup of patients with classic MS” (Comabella, 2014). All
molecular guidelines used at present in MS clinical practice are the proteins, and those
that measure humoral immune response are easier to integrate into clinical practice
(Comabella, 2014). Further, CSF is one of the most informative body fluids in which to
measure guidelines of disease because the pathological processes of the patients with MS.
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However, the CSF is obtained by an invasive procedure that restricts repeated collection
and can make it challenging in clinical practice.
Thus, the use of diagnostic guidelines detected in other body fluids such as IgG
oligoclonal bands in tears may warrant further investigation for better application in
clinical practice (Comabella, 2014). The ideal test to appropriately measure a guideline
should have solid analytical and clinical precision and should be clinically useful to
improve patient outcomes.
Infectious agents have also been suggested to have a role in terms of
environmental factors in MS. This includes the gastrointestinal commensal bacteria
having been implicated in the pathogenesis of autoimmune diseases like MS. Identifying
a unique gastrointestinal and oral bacteria derived lipedipeptide, Lipid 654, which is
produced by commensal bacteria and functions as a human and mouse like Toll-like
receptor 2 ligand, may help in the diagnosis of MS (Farrohki, et, al., 2013). Lipid 654 is
expressed at significantly lower levels in the serum of patients with MS compared to
healthy individuals (Farrohki, et, al., 2013). But there is still no clear pathogenesis of MS
as several theories exist out there regarding the exact cause and mechanism of the disease
(Farrohki et, al., 2013).
Peer-reviewed evidence also validates clinicians’ use of McDonald MS guidelines
because of its effectiveness for diagnosing MS, across other therapeutic areas that have
the same type of mechanism as MS. Clinicians should implement this measure tool
because there is an immediate need to improve patient outcome and personalized
medicine. The correlation is important because these protein and antibody factors helps
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clinicians with an intent to use a specific guideline and thus guide their therapeutic
treatment.
Other important peer- reviewed articles show that a biomarker blood test can
determine the type of MS someone has with an accuracy of 85 to 90 %, and thus improve
patient outcome by allowing clinicians to adapt to treatments faster (Farrohki et, al.,
2013). A potential guideline that involves tryptophan in which researchers look at the
importance of that being known to be involved in brain inflammation. A reliable
guideline will guide personalized treatment for each patient, which will improve patient
outcomes. However, further research is still needed on this diagnostic guideline, as there
are other diseases associated with inflammation and neurodegeneration besides MS and
that includes Alzheimer’s, Parkinson’s, and Lou Gehrig’s disease (Farrohki, et, al., 2013).
Separating MS from other neurodegeneration and inflammatory conditions with
this guideline and trying to separate from Alzheimer’s or Parkinson’s disease can be
challenging considering the various disease states that have inflammatory conditions, so
there is a need for a precise guideline.
Studies show that using high throughput body profiling by MALDI-TOF mass
spectrometry, small proteins and peptides have been detected as promising candidate
guidelines for disease diagnosis and disease progression of MS (Teunissen et, al., 2011).
The strength of this study is the potential for promising clinical biomarkers for clinicians
to adapt to, and the weakness with this is still investigating MALDI-TOF mass
spectrometry and how this plays a significant role in MS guidelines. The rationale for this
study is that it provides physicians another opportunity to use guidelines considering
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potential new candidates for MS disease diagnosis like mass spectrometry that have not
existed before. The correlation with this study is clinical factors that are produced from
electric and magnetic fields and a clinician’s intent to use a guideline (Teunissen, et, al.,
2011).
These research studies support this because it discusses the importance of the
development of these process specific therapies which will be impossible without the use
of guidelines that reflect the targeted process and how this target process can aid in the
more rapid screening of therapeutic agents as well (Bielekova, 2004). This is crucial
because having this process-specific guideline is a reason why it cannot serve as a
surrogate for a clinical outcome because of the complexity of MS (Bielekova, 2004). The
strength of this study is that with more of a targeted approach it will help the therapeutic
approach and aid in a more rapid screening process and in the development of therapeutic
agents. The weakness in this approach is that there is a high degree of complexity of
understanding MS because of the complexity of the disease and the difficulty of finding a
single guideline (Bielekova, 2004).
The rationale for this approach is a clinician’s intent to use a McDonald MS
guideline by understanding this as a measurable tool that has a great ability to be targeted
specifically for MS patients since challenges do exist that are being presented by being
such a complex disease. The correlations are important that are presented in this study
because the importance of identifying clinical factors through an effective screening
process is important in MS along with the development of immunotherapy agents. The
controversy with this study is the complexity of MS and how the complexity of the
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disease will be difficult to identify a single guideline to improve clinical outcome
(Bielekova, 2004).
The findings from the following studies demonstrate an important point because
this study shows significant changed expression of selected extracellular miRNA in
plasma of MS patients. This is important because these observations may help suggest
that miRNA subsets may be potential guidelines for MS activity (Kacperska, et, al.,
2015). The strengths of this study are that even though an ideal guideline of MS has still
not been found, the strength is that a group of endogenous, single-stranded noncoding
RNA molecules shows promise (Kacperska, et, al., 2015). With a better understanding of
microRNA profiles in each disease may aid in a quicker and accurate diagnosis while
also having universal prognostic factors. The weaknesses of this study are that the use of
miRNA expression differs depending on a stage of MS whether it is relapse vs remission.
The rationale for this approach is significant because these miRNA molecules
could aid in a quicker and accurate diagnosis (Kacperska et, al., 2015). This is important
because a quicker and accurate diagnosis will improve patient outcome for MS patients.
The correlation in this study is important because looking at clinical factors such as
microRNA profiles of patients provides physicians with an intent to use guidelines and
effective immunotherapy treatments. The controversy with this study is that more
research needs to be done in this area especially in turn how useful in clinical practice
these new guidelines could really be effective.
The study supports the significance of this because it discusses the
neuroinflammatory imaging guidelines this could provide accurate and more complete
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picture of MS, which in turn will help with therapeutic strategies. The strengths of this
study are that it provides another perspective at looking at identifying guidelines and
provides a complete picture of MS, especially our understanding of acute lesion
pathophysiology and its noninvasive follow-up. This is relevant because this approach
will provide in vivo sensitive and specific look at MS components to improve the
diagnostic performance, the pathophysiology, and our ability to follow the course of this
disease when looking at the future of therapeutic development and monitoring (Tourdias,
2013). The weakness of this study is the complex cascade of events that could take place
with acute inflammatory lesions like cell recruitment and edema formation. There can be
an issue with this because there are other guidelines of consequences of acute
inflammation like matrix digestion by metalloproteinase, acute demyelination, and axonal
injury (Tourdias, 2013).
The rationale for this study is that it provides another angle at looking at potential
guidelines for MS, especially from an imaging perspective. These MRI and positron
emission tomography markers of neuroinflammation will be a valid approach to assess
the neurodegeneration component of MS, particularly the axonal loss and incomplete
remyelination (Tourdias, 2013). The correlation is important in this study because clinical
factors of inflammation provide clinicians with an intent to use a guideline and effective
immunotherapy. “The controversy around this study is that there are other markers of
inflammation that need to be considered here, so the research is still ongoing in
identifying a single inflammatory guideline including looking at neuroimaging (Tourdias,
2013).
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Further research validates that these proteins semaphorin 7A and ala-Bdipeptidase can play an important role as CSF biomarkers (Canto, et, al., 2014). The
strengths of this study are that it provides some validation of specific proteins as
biomarkers while using different techniques in individual CSF samples. The weakness is
that in this study there were other proposed proteins as candidates for guidelines were not
validated in the individual CSF samples.
The rationale for this study is to look at how different proteins play a role in
guidelines, and which ones are more specific than others in determining an appropriate
guideline candidate for MS (Canto, et, al., 2014). The correlation is relevant because of
the clinical factors of particular proteins that patients may exhibit and a clinician’s intent
to use a guideline and effective immunotherapy. The controversy with this study is trying
to identify which proteins are more valid than others as the study has identified
appropriate candidates and not valid candidates for potential guidelines.
Additional studies are crucial because additional studies discuss the glial
potassium channel KIR4.1 as potential guideline. According to the research antibodies
against KIR4.1 were observed in 46.9% of patients with MS, but were essentially absent
in people with other neurological diseases and healthy donors (Wunsch et, al., 2014). The
strengths of this study are significant because the impact of immune responses against
antigens of gastric parietal cells on the KIR4.1 reactive antibody in patients with MS is
clinically significant (Wunsch et, al., 2014). The weakness of this study is that in the data
only 2 of 19 serum IgG positive MS patients also had detectable levels of KIR4.1
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antibody in the CSF so there still needs to further clarity on the research (Wunsch et, al.,
2014).
The rationale for this study is that KIR4.1 antibody could play an important role
in identifying new guidelines for clinicians. The correlation in this study is clinical
factors associated with KIR4.1 antibody are an important because this provides validation
for clinician’s intent to use a guideline when patients have these KIR4.1 antibody. The
controversy with this study is the clarity that needs to be confirmed regarding KIR4.1
antibody as research is still ongoing regarding showing resulting pathological effects in
the CNS and gut (Wunsch et, al., 2014).
Additional study is important because it looks at the activation of the kynurenine
pathway of tryptophan metabolism results from chronic inflammation like MS. Also, the
kynurenine pathway of the tryptophan metabolism is highly inducible in inflammatory
environments, and that changes in KP may be associated with MS (Kim, et, al., 2017).
The strength of this study is that researchers are constantly considering biochemical
pathways that are causing MS like the KP pathway. Also, the conclusions of the study
show a strong association with KP parameters and MS subtype. The weakness associated
with this study is this study only looked at tryptophan and unfortunately was not capable
of looking at downstream KP metabolites (Kim et, al., 2017).
The rationale for this study is that additional biochemical pathways exist in
looking at identification of MS guidelines and further validates this as a viable option as a
guideline. The correlation with this study is important because this shows clinical factors
that patients may have because of disruptions in these biochemical pathways and a
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clinician’s intent to use guidelines. The controversy with this study is that it did not look
at other downstream KP metabolites (Kim et, al., 2017).
Furthermore, additional articles show that 40% of MS cases studied it shows
detectable alpha-GA1C reactivity, which is potentially indicative of a particular type of
MS in terms of disease course and severity (Menge et, al., 2005). The strength of this
study is that mechanisms have been postulated with galactocerebroside and how this can
be implemented in the near future. The weakness of this study is that pathophysiological
explanation for the delayed response is not known. The rationale for this study is
exploring additional novel findings which demonstrate guideline capability for MS
diagnosis, staging, and prognosis (Menge et, al., 2005). The correlation that is important
in this study is clinical factors such as patients having these enzyme disruptions with
galactocerebroside and a clinician’s intent to use guidelines and immunotherapy. The
controversy with this study is the need for clarity around the pathophysiological
explanation with MS.
The importance of this study demonstrates that immunophenotyping of CSF cells
in MS is becoming more important to correlate cellular subsets with different disease
activity and remission (Alvermann et, al., 2014). The strength of this study is that
characterization of CSF cells allows researchers to understand MS pathogenesis and to
provide appropriate guidelines, individual prognosis, and treatment decisions (Alvermann
et, al., 2014). The weakness of this study is that other leukocyte populations including
natural kills cells, monocytes, and dendritic cells show variation as well (Alvermann et,
al., 2014). The rationale for this study is considering additional perspective on intent to
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use guidelines. The correlation with this study is how these CSF clinical factors can play
a role in clinician’s intent to use guidelines and immunotherapy. The controversy with
this study is that several other leukocyte populations need to be further examined.
The next study shows that lipid dysregulation plays a role in MS progression of
disability. The strength of this study is the identification of novel cholesterol subsets and
plasma triglycerides in MS patients including the use of the treatment of simvastatin
(Alvermann et, al., 2014). The weakness of this study is that these results were
independent of age and sex. The rationale for this study is to demonstrate the importance
that lipid dysregulation plays with people with MS as it pertains to progression and
disability. The correlation is important because clinical factors like lipid dysregulation
plays a role in clinician’s intent to identify a guideline. The controversy with this study is
that these results are independent of age and sex, and also could discriminate disease state
with high specificity and sensitivity (McKechnie, 2017).
Additional studies are important to address because this states that a useful
guideline in MS would allow for early identification of MS patient subsets and guide
their personalized treatment plan. The study discusses that the only robust guidelines
utilized in current practice are the MRI and CSF oligoclonal bands, but both which
provide limited prognostic information (Butterworth et, al., 2015). The strengths of this
study are that the study succeeded in showing a gene SLC9A9 associated with treatment
response. “The study discusses altered gene expression could lead to altered
glycosylation, an important mechanism regulation inflammation, implicating gene
variation in regulation of proinflammatory lymphocyte activation and thereby disease
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activity” (Butterworth et, al., 2015). The weaknesses in this study are that some plasma
levels in MS have not demonstrated sufficient specificity and sensitivity to be a viable
guideline.
The rationale for this study is that it shows that robust guidelines solutions do
exist but do not provide enough information to create the most efficient prognostic
measurable tool (Butterworth et, al., 2015). This study discussed other options including
gene expression which can play an important role in the inflammatory process and MS.
The correlation in this study is that patients that exhibit gene expression led to clinician’s
intent to use guidelines for future immunotherapies. The controversy within this study is
the challenge to develop a guideline with efficient prognostic solutions since robust
guideline exist, but not enough to produce prognostic information that clinicians are
expecting.
After an extensive search of the literature, I did not find other studies that used
gender, years in practice or knowledge about a targeted content to predict intent.
However, there are other recent studies that examine gender as a predictor for an
outcome. Wlodarczyk (2020) examined gender and predictors of post-MI HRQoL
(health-related quality of life) and found a difference between female and male survivors
of a myocardial infarction (Wlodarczyk, 2020) Additional studies focused on gender
included patient gender differences in the prediction of medical expenditures (Bertakis,
2010) and gender differences in determinants and consequences of health and illness
(Vlassof, 2007).
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Review of the Proposed Methodology
The research design for the proposed study was a quantitative correlation study to
examine the relationship between the independent variables including gender, McDonald
MS guideline knowledge, and years in practice, and the dependent variable intent to use
the guidelines.
Lynd (2014) used correlation and regression analysis first study looked at
quantitative analysis of MS patients’ preferences for drug treatment as the objective was
to elicit patients’ preferences for different attributes of MS drug therapy (Lynd et, al.,
2014). The second study looked at a comparative quantitative study of axonal injury in
active, inactive, and remyelinated lesions with MS. The objective of this study discussed
the importance of magnetic resonance studies of MS lesions indicate that axonal injury is
a major correlate of permanent clinical deficit (Kornek et, al., 2000). The third study is a
quantitative study of water diffusion in MS lesions and normal appearing white matter
using Echo-Planar imaging. “The objective of this study shows that diffusion-weighted
imaging is able to identify MS lesions with severe tissue disruption” (Flippi et, al., 2000).
These additional citations and references demonstrated the quantitative methodology is
sound and has been used by other researchers. Specific to my proposed analysis method
of binary logistic regression several studies have been found in the literature. Boamah
analyzed predicting social trust with give demographic variables from a national sample
of individuals who participated in the General Social Survey (GSS). (Boamah, 2015).
Schober (2021) analyzed the association between the induction technique and the risk of
hypoxemia while controlling the potential confounders (Schober, 2021). Bucor (2017)
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examined binary logistic regression instrument for assessing museum indoor air impact
on exhibits (Bucor, 2017).
Summary and Conclusions
The major themes in the study include the role of epidemiology of guidelines in
MS, the public health impact of MS, MS prevention history and current state, the MS
diagnostic history and current state, and finally the lack of correct and consistent use of
guidelines along with additional studies with my proposed methodology. I addressed the
importance of how prevalent MS is and the need for clinicians to use an effective
guideline to not only help MS patients but also the field of public health. The
development and use by clinicians’ of effective McDonald MS guidelines, the public
health field can be positively impacted because effective guideline use this will lead
toward more personalized and targeted care for these patients in order to improve patient
outcome. The study highlighted a call from the profession to use the MS guidelines in
clinical practice. There is a clinical need for not only MS, but also across other
therapeutic inflammatory areas that have the same type of mechanism. Furthermore, with
this study it provides clinicians another opportunity to use guidelines considering
potential new candidates for MS disease diagnosis like mass spectrometry that have not
existed before. Another major theme in this study is that it provides another perspective
at looking at potential guidelines for MS, especially from an imaging perspective. These
MRI and position-emission tomography markers of neuroinflammation will be an
excellent approach to assess the neurodegeneration component of MS, particularly the
axonal loss and incomplete remyelination (Tourdias, 2013). These are important studies
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because clinical factors of inflammation provide clinicians with an intent to use
guidelines and effective immunotherapy. Finally, the importance of having a sustainable
measurable MS guideline is critical in the field of medicine and public health as patient
outcome will improve along with improvement on the economic burden of patients in
society. An effective MS guideline tool provides a solution for clinicians to effectively
diagnose, monitor, and treat MS patients with more accuracy and precision to improve
patient outcome. In Chapter 3, I discuss the research design and rationale, methodology,
threats to validity all of which was an important aspect in this research.
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Chapter 3: Research Method
The purpose of this quantitative study was to explore the relationship between
selected physician characteristics including gender, McDonald MS guideline knowledge,
and years in practice and intent to use the new guidelines for diagnosing MS. I collected
data with a survey administered by email to practicing physicians from across the
Midwest. The study addressed what physician characteristics might be associated with
intent to use McDonald MS guidelines for the diagnosis, monitoring, prevention, and
treatment of MS. The major sections of this chapter include a description of the research
design and rationale, methodology, threats to validity, and summary.
Research Design and Rationale
This was a quantitative study with bivariate and regression analysis. The
independent variables included gender, McDonald MS guidelines knowledge, and years
in practice, and the dependent variable was intent to use the guidelines for the diagnosis
and prevention of MS. A quantitative research design was appropriate given the nature of
the RQs. The time and resource constraints consisted of waiting for the return of the
survey data from the physicians with their busy schedules seeing patients. A detailed and
specific follow up reminder email was provided to the physicians to encourage them to
take and return the survey. In addition, I emailed reminders every week throughout the
duration of the data collection phase of the research project.
Research Questions and Hypotheses
The RQs and accompanying null and alternative hypothesis for this study are:
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RQ1: What is the association between gender and the intent to use the guidelines?
Null Hypothesis: There is no association between gender and intent to use the guidelines.
Alternative Hypothesis: There is an association between gender and intent to use
the guidelines.
RQ2: Research question: What is the association between guidelines knowledge
and intent to use the guidelines?
Null hypothesis: There is no association between guidelines knowledge and intent
to use the guidelines.
Alternative Hypothesis: There is an association between guidelines knowledge
and intent to use the guidelines.
RQ3: Research question: What is the association between years in practice and
intent to use the MS guidelines?
Null Hypothesis: There is no association between years in practice and intent to
use the guidelines.
RQ4: To what extent do gender, guideline knowledge, and years in practice
predict intent to use the guidelines?
Null hypothesis: Gender, guidelines knowledge, and years in practice do not
predict intent to use guidelines.
Alternative Hypothesis: Gender, guidelines knowledge, and years in practice do
predict intent to use guidelines.
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Methodology
Population
The target population was practicing physicians (neurologists and primary care
physicians) in the Midwest who diagnose and treat MS patients. The study population
was practicing MD and D.O physicians who were either in private or hospital-based
practice.
Sampling and Sampling Procedures
The study population consisted of MD and D.O. physicians across several states
(Missouri, Illinois, Kansas, Oklahoma, Iowa, Arkansas, Nebraska) in the Midwest who
treat MS patients. Convenience sampling was used because of constraints of time and
other resources. I chose to purposefully sample physicians residing in states near where I
live in Missouri. The study participants were identified with an online search of all
neurologists and primary care physicians in network who treat MS patients within the
Midwest. Potential participants were invited via email to participate in the study. Those
who agreed were asked to take a survey using Survey Monkey. Physicians who do not
treat these types of MS patients or who currently use the guidelines were excluded from
the study.
Procedures for Recruitment, Participation, and Data Collection
Recruitment Procedures
The steps for recruitment included emailing invitations to the physicians to
participate in the study. I determined eligibility, ensuring that that the participants treat
MS patients, through online searches of potential participants’ specialty and exact patient
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population. This included both the neurologists and primary care physicians holding an
M.D. or D.O degree and license to practice medicine in their state. I screened potential
candidates using a short screening questionnaire when they accessed Survey Monkey. I
then provided access to a previously developed self-administered survey on Survey
Monkey. The participants provided informed consent acknowledgement on the first page
before they took the survey to ensure that privacy and informed consent was respected.
For collecting data, I implemented response validation in which I made sure respondents
submitted their answers in the right format. Follow up procedures included my contact
information and email had any of these physicians wanted to contact me for a follow up
interview, live visit, or phone call.
Minimum Sample Size Calculation
I calculated the minimum sample size needed for this study using the G Power
calculator for sample size computation for binary logistic regression (Faul, et
al.,2009). This calculation was based on one dichotomous independent variable, gender
(male/female) and the dichotomous outcome, intend to use or do not intend to use the
McDonald guidelines for diagnosing MS. Because of the lack of published research on
the use of the McDonald guidelines, and based on my personal experiences working with
physicians who treat MS, I hypothesized that male physicians were more likely to state
intent to use the guidelines than women physicians. However, the final gender
distribution of the sample consisted of 47% male physicians and 53 % female
physicians. Thus, assumptions were made that 50% of male physicians and 30% of
female physicians would state their intent to use the McDonald guidelines. It was
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determined that a minimum sample size of 312 respondents would be needed for the
analysis for an odds ratio (OR) of 2.3, and 95% power (see Figure 1). I attempted to
recruit at least 500 respondents to increase the power of the study. However, despite
several attempts to recruit more potential participants, I was not able to achieve the 500
goal. The final sample size for this study was 161 physicians.

Figure 1
G Power Output for Sample Size Calculation for Binary Logistic Regression,
Dichotomous Independent, and Dependent Variable
Options:
Analysis:
Input:

Output:

Large sample z-Test, Demidenko (2007) with var corr
A priori: Compute required sample size
Tail(s)
= Two
Odds ratio
= 2.3333333
Pr(Y=1|X=1) H0
= 0.3
α err prob
= 0.05
Power (1-β err prob)
= 0.95
R² other X
= 0
X distribution
= Binomial
X parm π
= 0.47
Critical z
= 1.9599640
Total sample size
= 312
Actual power
= 0.9500790

Procedures for Informed Consent
The informed consent process involved giving adequate information concerning
the study, providing sufficient opportunities for the participants to consider all options,
responding to the subject’s questions ensuring that the subject had comprehended this
information while obtaining the participants voluntary agreement. For informed consent,
a drafted word document with a voluntary agreement for physicians to participate in this
research using the Walden Informed Consent template was provided. This informed
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consent was provided in written format, sent by email to each participant who indicated a
willingness to participate. The physicians understood the research and the risks involved
within a written consent. If reading the informed consent document and they have
questions, they would respond to questions by email within 48 hours of receipt. There
will be immediate follow up to the physician if there are any missing data. The survey
was non-anonymous and confidential was guaranteed with informed consent. This was
designed to capture any reported changes or final questions that the physicians may have,
and physicians were able to contact me directly via email or phone. No physicians
contacted me regarding follow up. Also, the study was approved by the Walden (IRB #
01-21-20-0311462).
Data Collection
Data was collected in writing via an electronic survey accessed by participants
online using the Survey Monkey software. Data was collected from March 2020-August
2020. The survey had five parts including: the screening tool for eligibility, the informed
consent form, the demographic data form, the main survey questions, and closing
paragraph and form (see Appendix A). The sampling frame included all the physicians
with an MD or DO degree and license to practice medicine in their state in community
practice which included neurologists and primary care physicians who treat MS patients
in the Midwest.
Consensus Validity for the Survey
To increase the internal validity of the survey that I developed, I consulted with a
panel of three practicing physician/experts on MS who reviewed the content of the survey
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for accuracy and construct validity to achieve consensus validity. The names and contact
information of the panelist were provided to my committee chair for review and approval.
Results of the review were made available to my committee members. The panelists
provided encouraging feedback that the survey being used was accurate with the study.
Pilot Study
I conducted a small pilot study prior to implementing the main study. I selected
three physicians similar to the physicians in my main study in order to test my sampling
strategy, the ease and logic of taking the survey-on Survey Monkey, and completeness
and clarity of my survey data collection instrument. I first received approval from the
IRB before conducting the pilot study. As a result of the pilot study and encouraging
feedback from the three physicians I proceeded to the next steps. I did not do any analysis
of data with the pilot study. Overall, I received positive comments from the three
physicians regarding the sample strategy feedback, ease and logic of taking survey, and
completeness and clarity of my survey data collection instrument.
Data Analysis
Since my outcome of interest is physicians’ perceptions and intent to use
McDonald MS guidelines for diagnosing MS, I used binary logistic regression for the
bivariate analysis.
The software used for the analysis was SPSS version 27. My data preparation and
cleaning plan included checking and dealing with missing data, linearity, outliers,
multicollinearity, and homoscedasticity. The primary RQs for this study were: RQ1:
What is the association between gender and the intent to use the guidelines? RQ2: What
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is the association between McDonald MS guideline knowledge and intent to use the
guidelines? RQ3: What is the association between years in practice and intent to use the
MS guidelines? RQ4: To what extent do gender, guidelines knowledge, and years in
practice predict intent to use the guidelines?
The analysis plan included a descriptive analytical component consisting of the
use of percentages distributions and measures of central tendency to describe the
population and the responses to attitude, knowledge, beliefs, and behaviors of the
diagnostic tool (See Table below) The analysis plan included an inferential statistical plan
with the bivariate analysis and multiple logistic regression for the multivariate analysis
and predictor modeling. (See Table 1 below) The results were interpreted with
confidence intervals as confidence intervals are important when analyzing the results of
statistical analysis to help interpret the P-values obtained.
Data Analysis Matrix
Table 1 shows a summary of the overall data analysis plan for the study. Please
see Appendix B for the Mock Tables used in the data analysis. The three specific
predictor variables are gender, McDonald MS knowledge of Guidelines, and years in
practice.
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Table 1
Data Analysis Plan for Study
Study Objective
or Research
Questions
RQ I. What is the
association
between gender
and the intent to
use the guidelines
RQ II. What is the
association
between guideline
knowledge and
intent to use the
guidelines

RQ III. What is
the association
between years in
practice and intent
to use the
guidelines
RQ IV. To what
extent do gender,
guideline
knowledge, and
years in practice
predict intent to
use the guidelines

Concept

Data
Source

Level of
Measurement

Analysis
Procedures

Logistic
Regression

Association
between gender
and intent to use

Survey
instrument

Binary

Binary logistic
regression

Binary
Logistic
Regression

Association
between guideline
knowledge and
intent to use.
Measured by a
short quiz question
and dichotomous
score by Pass/Fail
Association
between years in
practice and intent
to use

Survey
instrument

Binary

Binary logistic
regression

Binary
Logistic
Regression

Survey
instrument

Binary

Binary logistic
regression

Binary
Logistic
regression

Association
between gender,
guidelines
knowledge, and
years in practice
and intent to use

Survey
instrument

Multivariate

Binary logistic
regression

Multiple
Logistic
regression
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Threats to Validity
The threats are relevant to my proposed study because of my quantitative study
design in which a survey was used to collect data. In the design of my study, the threats
to external validity consist of population and ecological validity, while the internal threats
consist of statistical regression and selection. The reasons these are external threats is
population validity is this type of external validity that can create assumptions regarding
extrapolation of the entire population as a whole. The internal threats of statistical
regression because the scores of individuals may be extremely high or low, and selection
can be an internal threat based on the comparability before the study.
Ethical Procedures
Ensuring that participants can refuse to participate without repercussions is an
ethical guarantee that was included in this study. Although this study was confidential, it
was not fully anonymous since the participants could be traced through their IP address.
The treatment of the data was kept confidential and only used solely for the purpose of
the study. Protection of the data collected and implementing storage practices to ensure
privacy were applied. Strict care was taken to avoid breaches of confidentiality in which
information is provided to others. I submitted an application to the IRB for permission to
collect data for the pilot and main study and was granted permission (IRB: 01-21-200311462). I stored the data in my office in a locked cabinet in a file folder for the
duration of the study and will keep the data for a minimum of five years.
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Summary
The methodology used was a quantitative correlational study. Data was collected
by electronic survey using the survey monkey software. Data was be kept confidential
and used solely for the purpose of the study. Protection of the data collected and
implementing storage practices was applied and enforced for the participants not to
discuss the survey outside of the research context. In Chapter 4, I present my research
findings.
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Chapter 4: Results
The purpose of this quantitative correlational study was to examine the
relationship between the independent variables gender, McDonald MS guidelines
knowledge, and years in practice, and the dependent variable of intent to use guidelines
among practicing physicians in Missouri, Kansas, Oklahoma, Iowa, Illinois, and
Nebraska. I examined the association among gender, knowledge, and years in practice
and intent to use the guidelines. The RQs and accompanying null and alternative
hypothesis for this study are:
RQ1: What is the association between gender and the intent to use the guidelines?
Null Hypothesis: There is no association between gender and intent to use the guidelines.
Alternative Hypothesis: There is an association between gender and intent to use
the guidelines.
RQ2: Research question: What is the association between guidelines knowledge
and intent to use the guidelines?
Null hypothesis: There is no association between guidelines knowledge and intent
to use the guidelines.
Alternative Hypothesis: There is an association between guidelines knowledge
and intent to use the guidelines.
RQ3: Research question: What is the association between years in practice and
intent to use the MS guidelines?
Null Hypothesis: There is no association between years in practice and intent to
use the guidelines.
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Alternative Hypothesis: There is an association between years in practice and
intent to use the guidelines.
RQ4: To what extent do gender, guideline knowledge, and years in practice
predict intent to use the guidelines?
Null hypothesis: Gender, guideline knowledge, and years in practice do not
predict intent to use the guidelines
Alternative Hypothesis: Gender, guidelines knowledge, and years in practice do
predict intent to use the guidelines.
Chapter 4 includes a description of a pilot study conducted, data collection,
reporting of findings from descriptive statistics and inferential analysis of the data, and a
summary.
Pilot Study
I recruited three physicians similar to the physicians in my main study in order to
test my sampling strategy, the ease and logic of taking the survey on Survey Monkey, and
completeness and clarity of my survey data collection instrument. Data from the pilot
study participants was not included in the main study. There were no results from the
pilot study as the purpose was get the administrative protocol established. I first received
approval from the IRB before conducting the pilot study. There were no changes needed
to my data collection protocol, the survey content, or the participant recruitment
strategies. Permission was then obtained from my committee and the IRB to proceed to
the data collection for the main study. I did not do any analysis of the data during the
pilot study.
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Data Collection
Data were collected in writing via an electronic survey accessed confidentially by
participants online using Survey Monkey. The survey had five parts: the screening tool
for eligibility, the informed consent form, the demographic data form, the main survey
questions, and closing paragraph and form. The sampling frame included all the
neurologists and primary care physicians who treat MS with an M.D. or D.O. degree and
license to practice medicine in Missouri, Kansas, Oklahoma, Iowa, Illinois, and
Nebraska. Data were collected from April 2020 to July 2020. A total of 161 participants
completed the survey, though the original goal was to recruit 500 participants. Despite
several attempts to increase the response rate with multiple email reminders no additional
participants were recruited. Participants provided demographic information that included
gender, race, McDonald MS guidelines knowledge and years in practice. Data were
analyzed using version SPSS 27.
Descriptive Statistics
The study sample included 75 males (46.60%) and 86 females (53.40%). Most
were not Hispanic or Latino (n=141, 87.00%). The average years in practice was 11.18
(M = 11.18; SD= 10.51). There were 21 Hispanic or Latino (13.00%) and 141 not
Hispanic or Latino (87.00%). One participant was American Indian or Alaska native
(0.60%), 12 were Asian (7.40%), 13 were Black or African American (8.00%), 4 were
Native Hawaiian or another Pacific Islander (2.50%), and 132 were White race (81.50%).
The average years in practice was 11.18 (M=11.18; SD = 10.51). Fifteen participants
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were very likely to use guidelines (9.30%), whereas 68 were very unlikely to use
guidelines (42.00%).
Table 2
Descriptive Characteristics of Study Sample
Variable
Gender
Male
Female
Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Race
American Indian or Alaska Native
Asian
Black or African American
Native Hawaiin or Pacific Islander
White
Total

N

%

75
86

46.60
53.40

20
141

13.00
87.00

1
11
13
4
132
161

0.60
7.40
8.00
2.50
81.50

Table 3
Geographic Distribution of Survey Respondents
Geographic
distribution
Private practice
Hospital
Totals

Yes (Number)%

No (Number)%

Total (Number)%

0(0) %
161(100) %
161(100) %

161(100) %
0(100) %
161(100) %

161(100) %
161(100) %
161(100) %

Table 4
Participants Who Stated Intent to Use Guidelines
Intent to use guidelines
Yes
No
Totals

Yes (Number)%
42(26.6) %
119(42) %
161(100) %

No (Number)%
119(42) %
42(26.6) %
161(100) %

Total (Number)%
161(100) %
161(100) %
161(100) %
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Data Coding
Data were coded as gender 0 = female, and 1 = male, guideline knowledge given
for 0=fail and 1 = pass, years in practice was discreet, and intent to use 0 = no intent, and
1 = intent to use.
Bivariate Logistic Regression Analysis
A logistic regression analysis was conducted to assess the association between the
predictor variable, gender, and the outcome, the likelihood of stated, intent to use the
McDonald guidelines. (see Table 5). The null hypothesis tested for the adjusted OR is the
probability of being in the target group is equal to the probability of not being in the
target group (OR=1). The adjusted OR (.674) is less than 1.0, indicated a negative
association between gender and stated intent to use the McDonald guidelines. The P
value of the Adjusted OR is .322 and substantially greater than Alpha threshold of (.05)
and therefore not statistically significant. The Confidence Interval for the Adjusted OR
(lower: = 308; upper: =1.473) crosses 1.0 and is not statistically significant. Therefore,
the null hypothesis is not rejected. Gender is not associated with intent to use the
McDonald guidelines.
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Table 5
Bivariate Analysis: Gender

Step 1a

Gender (1)
Constant

B
-.395
-.298

S.E.
.399
.275

Wald
.979
1.176

df

Sig.
.322
.278

1
1

Exp(B)
.674
.742

95% C.I.for
95% C.I. for
EXP(B)
EXP(B)
Lower
Upper
.308
1.473

A logistic regression analysis was conducted to assess the association between the
predictor variable, knowledge, and the outcome, the likelihood of stated, intent to use the
McDonald guidelines. (see table 6) The null hypothesis tested for the adjusted OR is the
probability of being in the target group is equal to the probability of not being the target
group (OR = 1). The adjusted OR (1.065) is greater than 1.0, indicated a positive
association between gender and stated intent to use the McDonald guidelines. The p value
of the adjusted OR is .873 and substantially greater than Alpha threshold of (.05) and
therefore not statistically significant. The Confidence Interval for the adjusted OR
(lower=:.493; upper=:2.300) crosses 1.0 and is not statistically significant. Therefore, the
null hypothesis is not rejected. Knowledge is not associated with intent to use the
McDonald guidelines.
Table 6
Binary Logistic Regression: Knowledge and Years in Practice

B

S.E.

Wald

df

Sig.

95%
95%
C.I.for
C.I.for
EXP(B) EXP(B)
Upper
Exp(B) Lower
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Step 1a

Knowledge(1)
Constant

.063
-.486

.393
.259

.025
3.502

1
1

.873
.061

1.065
.615

.493

2.300

A logistic regression analysis was conducted to assess the association between the
predictor variable, years in practice, and the outcome, the likelihood of stated, intent to
use the McDonald guidelines. (see Table 7) The null hypothesis tested for the OR is the
probability of being in the target group is equal to the probability of not being in the
target group (OR=1). The OR (1.016) is greater than 1.0, indicated a positive association
between years in practice and stated intent to use the McDonald guidelines. The p value
of the OR is .379 and substantially greater than Alpha threshold of (.05) and therefore not
statistically significant. The Confidence Interval for the OR (lower: =.981; upper:
=1.051) crosses 1.0 and is not statistically significant. Therefore, the null hypothesis is
not rejected. Years in practice is not associated with intent to use the McDonald
guidelines.
Table 7
Binary Logistic Regression: Years in Practice

Step 1a

Years in Practice
Constant

B
S.E.
.015 .018
-.627 .275

Wald
.775
5.188

df
1
1

Sig.
.379
.023

95% C.I.for
95% C.I.for
EXP(B)
EXP(B)
Upper
Exp(B) Lower
1.016
.981
1.051
.534

Multivariate Analysis
A multivariate regression analysis was conducted to assess the relationship and
predictive value of the independent variables, gender, McDonald MS guideline
knowledge, and years in practice and the dependent variable, the intent to use guidelines.
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The sample included in the analysis was 106 instead of 161 due to the recoding of the
dependent variable to make it dichotomous to conduct the multivariate binary logistic
regression. The logistic regression equation is log(p/1-p) = 0.384*gender +
0.214*guideline knowledge + 0.015*years in practice.
The first step was to conduct a test multicollinearity test with the following
results. Results indicated no collinearity with a variance inflation factor of 1.0 for gender,
and 1.1 for knowledge and 1.1 years in practice.
The next step in the analysis was to conduct and examine a null regression model
where no independent variables were included in the analysis. The classification
accuracy for Block 0 (62%; p=.013) indicated a modest level of classification accuracy.
The interpretation of the results is that p = .013, therefore it is significant, and = .612 is
the odds ratio and that it is not significant. (see Table 8) The interpretation of the
confidence interval is that it is not statistically significant.
Table 8
Multivariate Analysis for Intent to Use Guidelines

Step 0

Constant

B

S.E.

Wald

-.491

.198

6.135

df
1

Sig.

Exp(B)

.013

.612

Multiple Logistic Regression Model
The final step was to test the regression model that included all independent
variables and the dependent variable. The omnibus test of coefficients model included the
independent variables as well as the dependent variables and tests the predictive capacity
of the model. There was no statistically significant difference between the Log-likelihood
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of the baseline model and new model, with a chi-square of 2.044, df=3, and sig.=.563.
The predictive value of the regression model is not very high. The Nagelkerke R square
value (.026) indicates the amount of variation accounted for in the dependent variable,
indicating a small variation. The Hosmer and Lemeshow test for goodness of fit for
logistical regression models. predictive value of the regression model is not very high.
The result here (Chi-square = 5.529 Sig = .700) is non-significant. The null hypothesis is
rejected. The contingency (Table 9) indicates substantial differences between expected
versus observed values for most of the deciles, indicating the weakness of the model.
Table 9
Contingency Table for Hosmer and Lemeshow Test
Intent_to_use_guidelines =
No
Step 1

1
2
3
4
5
6
7
8
9
10

Intent_to_use_guidelines =
Yes

Observed
5
7
6
7
7
3
10
9
9

Expected
5.836
9.028
5.743
9.513
6.882
3.099
8.009
6.711
7.015

Observed
4
7
3
8
4
2
3
2
3

Expected
3.164
4.972
3.257
5.487
4.118
1.901
4.991
4.289
4.985

5

6.164

7

5.836

Total
9
14
9
15
11
5
13
11
12
12

The classification accuracy for Block 1 is indicated by 61.3% as the overall
percentage correct that was predicted regarding intent to use the guidelines. The
regression model classification accuracy was not an improvement over the null model, in
fact it was lower. (Null Model = 62%; Regression Model = 61.3%).
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The variable in equation is provided in table 9. The Wald statistic show that the
model is not significant as it does not add anything to the model. The Exp (B) are values
for the regression equation predicting the dependent variable from the independent
variable. The Exp (B), the odds ratio was not statistically significant.
Table 10
Variables in the Equation

.384

.408

.886

1

.347

1.468

95% CI
Lower
.660

.214

.408

.275

1

.600

1.239

.557

2.758

.015

.018

.697

1

.404

1.015

.980

1.051

-.947

.392

5.825

1

.016

.388

B
a
Step 1 Gender (1)
Knowledgeable (1)
Years in Practice
Constant

SE

Wald

df

Sig.

Exp(B)

95% CI
Upper
3.266

Summary
It was hypothesized that gender, knowledge of the new treatment guidelines, and
years in medical practice (independent variables) would predict intent to use the
McDonald MS guidelines (dependent variable) among physicians who treat multiple
sclerosis. A correlational analysis was conducted to assess the linear relationship between
all the variables of interest. There were positive but non-significant relationships between
the variables. A test for collinearity revealed the near absence for collinearity for each
independent variable (Gender 1.0 and 1.1 for knowledge 1.0 for years in practice).
Bivariate regression analysis for each independent variable and the dependent variable
indicated no statistically significant predictive power for each independent variable and
the outcome. The regression omnibus model had a poor predictive capacity for the
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outcome according to the analysis. (p = .563) Chapter 5 includes the interpretation of the
findings, limitations of the study, and recommendations for further study.
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Chapter 5: Discussion, Conclusions, and Recommendations
The purpose of this quantitative correlational study was to examine the
relationship between gender, McDonald MS guideline knowledge, and years in practice,
and intent to use the guidelines. The guidelines improve both the quality of care and
patient outcomes when correctly used by physicians and a adherence to the McDonald
clinical guidelines helps clinicians make appropriate clinical diagnosis and treatment
plans for MS patients. A test for collinearity revealed the near absence of collinearity for
each independent variable, with variance inflation factors of 1.0 for gender, 1.1 for
knowledge and 1.1 for years in practice. Bivariate regression analysis for each
independent variable and the dependent variable indicated no statistically significant
predictive correlation between each independent variable and the outcome. Lastly, the
regression omnibus model had a poor predictive capacity for the outcome. (Exp
(B)=.612; p = .563)
Interpretation of the Results
Test for Collinearity
The test for collinearity revealed the near absence of collinearity for each
independent variable with variance inflation factors of 1.0 for gender, and 1.1 for
knowledge and 1.1 for years in practice. Little or no collinearity allows the model a better
change to detect of each independent variable on the outcome if there is one. Yet, in this
study even with no collinearity my model was not a good model. This finding of nonsignificant relationships between other variables did not support my hypothesis based on
previous research.

52
Bivariate Analysis
Bivariate regression analysis for each independent variable and the dependent
variable indicated no statistically significant predictive power for each independent
variable and the outcome. My findings contradict the studies that have shown gender to
be a strong predictor or the outcome. For example, Carrol (2017) found that females have
a greater intent to use medical apps to improve their health compared to their male
counterparts, and females with higher education were more likely to use medical apps to
improve their healthcare outcomes. (Carrol, et, al.,) Deshpande (2009) also analyzed
gender and intent to eat a healthy diet among students, showing that males students
reported a lower intention to consume a healthy diet than did females (Deshpande, et, al.,
2009). Thus, gender and intent does exist, which contradicts my study findings.
Multivariate Analysis
The multivariate analysis for all independent variables combined and the
dependent variable indicated no statistically significant predictive power for the model.
My findings contradict previous studies using multivariate analysis that showed gender to
be a significant predictor. For example, Khatun (2017) showed that intention to use
mHealth services was high for both genders (Khatun et, al., 2017). Ng-Sueng (2016) also
analyzed gender as a predictor of the intent to choose a medical specialty like
obstetrics/gynecology and dermatology over general practice, suggesting that females had
an intent to choose obstetrics/gynecology, pediatrics, pediatric surgery, dermatology, and
oncology (Ng-Sueng et, al., 2016).
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Survey Results
Fifteen participants were very likely to use guidelines (9.30%), 26 were somewhat
likely to use guidelines (17.30%). 51 were neutral (31.50%) and 68 were very unlikely to
use guidelines (42.00%). Therefore, most were unlikely to use the guidelines, which is
supported in the peer-reviewed literature by Ghezzi (2018), who suggested that the
guidelines are not set rules, but rather only serve as a clinical guide for decision making
(Ghezzi, et, al., 2018). This means that some physicians do not see the importance and
will not follow suggestions.
Additional significant information regarding the survey is knowledge of the
guidelines. The majority were familiar with the guidelines, yet most said they were
unlikely to use them. Previous research has also shown that clinicians follow the
guidelines, and they agree that outcomes are improved, but they are not using them
because even though guidelines are clear and relevant, often they can still derail quality
improvement efforts. (Nelson, 2016). Further research has indicated that there was a lack
of agreement with the recommendations with a lack of evidence and environmental
factors (Luggenberg et, al., 2009). In my study the results showed that guideline
knowledge did not predict outcome.
Limitations of the Study
A key limitation is the small sample size (N = 161), which limits the power of the
analysis to detect an effect if there is one. This lessened the likelihood to find a
significant result and decreased the external validity, and the ability to generalize the
findings to other similar populations. Another limitation is the sampling method, which
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was convenience, non-random sampling and affected the external validity of the findings
because the population did not have an equal chance of being selected.
Recommendations
Recommendations for further studies include studies with a larger sample size to
include more clinicians’ from around the country. This will increase the power of the
study to detect an effect if one exists. Additional recommendations for developing a
survey and questionnaire in the future include adding more questions to the survey to
capture a larger amount of data. This additional information would include institutional
policies that clinicians’ have abide by along with added survey questions to test
clinicians’ awareness of educational tools they have access to in order to educate them
around their intent to use the guidelines.
Implications
The goal of this study was to examine physician characteristics that might be
associated with intent to use the McDonald MS guidelines. Knowing which factors are
associated with intent to use could help develop interventions to encourage their use.
Widespread and consistent intent to use guidelines could change how clinicians’
approach MS and provide them with the tools and knowledge to make more informed
diagnostic and treatment decisions to improve outcomes. MS significantly affects quality
of life (Rezapour et, al., 2017), which is important consideration in policy-making
decisions and health care outcomes in the public health field.
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Conclusion
MS is a growing global public health concern. (World Health Organization,
2016). As MS becomes more prevalent, it is more important to continue to follow the
McDonald MS guidelines to ensure adequate diagnosis and further treatment for MS
patients. Although this study did not confirm if there are physician characteristics factors
that might predict intent to use the guidelines, it is worth replicating the study with a
larger sample size to increase the power of the study. Increasing the physician’s
perceptions and intent to use guidelines for diagnosing MS may allow for continued
quality of care and improved outcomes to continue to promote evidence-based medicine.
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Appendix A: Survey Questions

A. PART 2: Demographic Information:
1. How old were you on your last birthday? (Please fill in a number)
________________
2.
A.
B.
C.
D.

What is your Gender? (Instructions-Choose the best answer)
Male
Female
Other________________
Prefer not to answer

3. What is your ethnicity? (Instructions-Choose the best answer)
A. Hispanic or Latino
B. Not Hispanic or Latino

4.
A.
B.
C.
D.
E.

What is your race? (Instructions-Choose the best answer)
American Indian or Alaska Native
Asian
Black or African American
Native Hawaiian or other Pacific Islander
White

5. How many years have you been in practice? (Please fill in a number)
________________
6. What is your intent to use the guidelines for biomarkers in the
diagnoses of MS? (Instructions: Choose the best answer)
A. Very Likely
B. Somewhat likely
C. Neutral
D. Very unlikely

C. Part 3: Knowledge on Guidelines:
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7. The McDonald diagnostic criteria were established in 1997?
(Instructions-Choose the best answer)
A. True
B. False
8. The McDonald diagnostic criteria were revised to clarify the
meanings of attack, dissemination and positive MRI? (InstructionsChoose the best answer)
A. True
B. False
9. There have been recent advances in the McDonald Diagnostic
Criteria? (Instructions-Choose the best answer)
A. True
B. False
10. According to Clinical Guidelines it is important to diagnose MS on
the basis of MRI findings alone? (Instructions-Choose the best
answer)
A. True
B. False
11. According to Guidelines clinicians should counsel people with newly
diagnosed MS about specific treatment options? (InstructionsChoose the best answer)
A. True
B. False
12. Specific criteria for diagnosing PPMS have not changed?
(Instructions-Choose the best answer)
A. True
B. False
13. According to the Guidelines there are recommendations to use the
presence of oligoclonal bands in CSF to make the diagnoses of MS?
(Instructions-Choose the best answer)
A. True
B. False
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14. What is your intent to use the guidelines for biomarkers in the
diagnoses of MS? (Instructions: Choose the best answer)
E. Very Likely
F. Somewhat likely
G. Neutral
H. Very unlikely
15. According to the Guidelines both symptomatic and asymptomatic
MRI lesions can be considered in determining DIT (dissemination in
time) and DIS?(dissemination in space) (Instructions: Choose the
best answer)
A. True
B. False
16. According to the Guidelines rapidly evolving severe RRMS is only
sensory symptoms only? (Instructions-Choose the best answer)
A. True
B. False
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Appendix B: Mock Tables
Table B1
Distribution of Gender of Study Participants (N = x)
Gender
Male
Female
Totals

Yes (Number)%
( )%
( )%
( )%

No (Number)%
( )%
( )%
( )%

Total (Number)%
( )%
( )%
( ) 100%

Table B1
Geographic Distribution of Participants (N = x)
Geographic
distribution
Private practice
Hospital
Totals

Yes (Number)%

No (Number)%

Total (Number)%

( )%
( )%
( )%

( )%
( )%
( )%

( )%
( )%
( ) 100%

Table B2
Number and Percent of Participants Who Stated Intent to Use Guidelines (N = x)
Intent to use
guidelines
Yes
No
Totals

Yes (Number)%

No (Number)%

Total (Number)%

( )%
( )%
( )%

( )%
( )%
( )%

( )%
( )%
( ) 100%

Table B3
Bivariate Statistical Analysis
Independent
Variable
Gender
Guidelines
Knowledge
Years in Practice

Dependent
Variable
Intent to Use
Guidelines
Intent to Use
Guidelines
Intent to Use
Guidelines

Chi Square
Value

DF

Sig
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Table B4
Output for Multiple Logistic Regression Analysis
Outcome:
Intent to Use
Guidelines
Intercept

Regression
Coefficient

Chi Square

P Value

Odds Ratio

Confidence
Interval
(95% CL)

